Drug Shortage Report for VENLAFAXINE XR
| Report ID | 72114 |
| Drug Identification Number | 02385945 |
| Brand name | VENLAFAXINE XR |
| Common or Proper name | VENLAFAXINE XR |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-03-04 |
| Actual start date | 2019-02-26 |
| Estimated end date | 2019-06-07 |
| Actual end date | 2019-06-07 |
| Shortage status | Resolved |
| Updated date | 2019-06-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-01-14 | French | Compare |
| v1 | 2019-01-14 | English | Compare |